DJIA 15,872.10 -332.87 -2.05%
NASDAQ 4,232.05 -131.10 -3.00%
S&P 500 1,835.57 -44.48 -2.37%
market minute promo

5.79 -0.53 (-8.39%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ACHN $5.79 -8.39%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.21
Previous Close $6.32
Daily Range $5.67 - $6.35
52-Week Range $5.67 - $12.94
Market Cap $790.6M
P/E Ratio -16.21
Dividend (Yield) $0.00 (0.0%)
Volume 1,592,237
Average Daily Volume 1,908,411
Current FY EPS -$0.12

Sector

Healthcare

Industry

Drug Makers

ACHILLION PHARMACEUTICALS, INC. (ACHN) Description

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases Website: http://www.achillion.com/

News & Commentary Rss Feed

Why Achillion Pharmaceuticals Shares Crashed 37% in January

Investors continue to sell off the once-promising developer of hepatitis C drugs.

Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global Ea

Zacks.com featured expert Kevin Matras highlights: Achillion Pharmaceuticals, Opko Health, Global Eagle Entertainment, LendingClub and Barracuda Networks

A Company's First Profit Can Mean Big Profits to Investors

Achillion Pharmaceuticals (ACHN) Weak On High Volume

First Week of ACHN September 16th Options Trading

The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceu

The Zacks Analyst Blog Highlights: Gilead, Horizon Pharma, AVEO Pharmaceuticals, Achillion Pharmaceuticals and Inovio Pharmaceuticals

Achillion Pharmaceuticals is Now Oversold (ACHN)

Commit To Purchase Achillion Pharmaceuticals At $5, Earn 12% Using Options

Bristol-Myers (BMY) Collaborates with Dual Therapeutics

Achillion Pharmaceuticals (ACHN) Flagged As Strong On High Volume

See More ACHN News...

ACHN's Top Competitors

ACHN $5.79 (-8.39%)
Current stock: ACHN
AMGN $143.07 (-1.36%)
Current stock: AMGN
GILD $85.72 (0.68%)
Current stock: GILD
BIIB $251.11 (-4.83%)
Current stock: BIIB